Hypoxia, such as encountered at high altitude, promotes deep vein thrombosis in mice

Journal of Thrombosis and Haemostasis

Volumn 11, Issue 9, 2013, Pages 1773-1775

  Brill, A ^a,b,c,d   Suidan, G L ^a,b,c   Wagner, D D ^a,b,c  

^a CENTER FOR BLOOD RESEARCH   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VON WILLEBRAND FACTOR;

ALTITUDE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; DEEP VEIN THROMBOSIS; EX VIVO STUDY; HYPOXIA; LEUKOCYTE; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY VEIN OBSTRUCTION; REOXYGENATION; TRAVEL;

ALTITUDE; ANIMALS; ANOXIA; MALE; MICE; MICE, INBRED C57BL; VENOUS THROMBOSIS;

EID: 84883814030     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12310     Document Type: Article

References (21)

1. Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol 2008; 28: 370-72.
2. Bovill EG, van der Vliet A. Venous valvular stasis-associated hypoxia and thrombosis: what is the link? Annu Rev Physiol 2011; 73: 527-45.
3. Gavish I, Brenner B. Air travel and the risk of thromboembolism. Intern Emerg Med 2011; 6: 113-16.
4. Silverman D, Gendreau M. Medical issues associated with commercial flights. Lancet 2009; 373: 2067-77.
5. Ferrari E, Chevallier T, Chapelier A, Baudouy M. Travel as a risk factor for venous thromboembolic disease: a case-control study. Chest 1999; 115: 440-44.
6. Rosendaal FR. Air travel and thrombosis. Pathophysiol Haemost Thromb 2002; 32: 341-42.
7. Kuipers S, Cannegieter SC, Middeldorp S, Robyn L, Buller HR, Rosendaal FR. The absolute risk of venous thrombosis after air travel: a cohort study of 8, 755 employees of international organisations. PLoS Med 2007; 4: e2901.
8. Li C, Jackson RM. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol 2002; 282: C227-41.
9. Wiles ME, Hechtman HB, Morel NM, Shepro D. Hypoxia reoxygenation-induced injury of cultured pulmonary microvessel endothelial cells. J Leukoc Biol 1993; 53: 490-97.
10. Kesteven P, Robinson B. Incidence of symptomatic thrombosis in a stable population of 650 000: travel and other risk factors. Aviat Space Environ Med 2002; 73: 593-96.
11. Wagner DD, Olmsted JB, Marder VJ. Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells. J Cell Biol 1982; 95: 355-60.
12. McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton DF. GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest 1989; 84: 92-99.
13. Bonfanti R, Furie BC, Furie B, Wagner DD. PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells. Blood 1989; 73: 1109-12.
14. Pinsky DJ, Naka Y, Liao H, Oz MC, Wagner DD, Mayadas TN, Johnson RC, Hynes RO, Heath M, Lawson CA, Stern DM. Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation. J Clin Invest 1996; 97: 493-500.
15. Bergmeier W, Chauhan AK, Wagner DD. Glycoprotein Ibalpha and von Willebrand factor in primary platelet adhesion and thrombus formation: lessons from mutant mice. Thromb Haemost 2008; 99: 264-70.
16. Brill A, Fuchs TA, Chauhan AK, Yang JJ, De Meyer SF, Kollnberger M, Wakefield TW, Lammle B, Massberg S, Wagner DD. von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood 2011; 117: 1400-71.
17. Toff WD, Jones CI, Ford I, Pearse RJ, Watson HG, Watt SJ, Ross JA, Gradwell DP, Batchelor AJ, Abrams KR, Meijers JC, Goodall AH, Greaves M. Effect of hypobaric hypoxia, simulating conditions during long-haul air travel, on coagulation, fibrinolysis, platelet function, and endothelial activation. JAMA 2006; 295: 2251-61.
18. Hodkinson PD, Hunt BJ, Parmar K, Ernsting J. Is mild normobaric hypoxia a risk factor for venous thromboembolism? J Thromb Haemost 2003; 1: 2131-33.
19. Kanaji T, Russell S, Ware J. Amelioration of the macrothrombocytopenia associated with the murine Bernard-Soulier syndrome. Blood 2002; 100: 2102-07.
20. Denis C, Methia N, Frenette PS, Rayburn H, Ullman-Cullere M, Hynes RO, Wagner DD. A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci USA 1998; 95: 9524-91.
21. Brill A, Yesilaltay A, De Meyer SF, Kisucka J, Fuchs TA, Kocher O, Krieger M, Wagner DD. Extrahepatic high-density lipoprotein receptor SR-BI and apoA-I protect against deep vein thrombosis in mice. Arterioscler Thromb Vasc Biol 2012; 32: 1841-71.